Sangamo Therapeutics Inc Cash Flow-to-Debt Ratio
Sangamo Therapeutics Inc cash flow-to-debt ratio. Sangamo Therapeutics Inc (SGMO) has a Cash Flow-to-Debt Ratio of -0.35x as of September 2025, meaning its operating cash flow of $-28.50 Million could theoretically repay 0% of its total liabilities ($82.40 Million) in one year. Check how high is Sangamo Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sangamo Therapeutics Inc (1999–2024)
Cash flow-to-debt ratio of Sangamo Therapeutics Inc from 1999 to 2024. Historical debt coverage capacity for Sangamo Therapeutics Inc across 26 annual periods. Check Sangamo Therapeutics Inc (SGMO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sangamo Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1999–2024)
Sangamo Therapeutics Inc cash flow-to-debt ratio by year from 1999 to 2024. Year-by-year debt coverage analysis for Sangamo Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Sangamo Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.85x | $-67.14 Million | $78.86 Million | ▲ +68.8% |
| 2023 | -2.73x | $-224.84 Million | $82.43 Million | ▼ -226.3% |
| 2022 | -0.84x | $-223.63 Million | $267.55 Million | ▼ -24.2% |
| 2021 | -0.67x | $-233.25 Million | $346.58 Million | ▼ -274.8% |
| 2020 | 0.39x | $169.88 Million | $441.18 Million | ▲ +154.6% |
| 2019 | -0.71x | $-144.40 Million | $204.78 Million | ▼ -524.9% |
| 2018 | 0.17x | $37.15 Million | $223.88 Million | ▲ +46.7% |
| 2017 | 0.11x | $11.18 Million | $98.84 Million | ▲ +103.7% |
| 2016 | -3.04x | $-65.88 Million | $21.70 Million | ▼ -123.3% |
| 2015 | -1.36x | $-33.72 Million | $24.80 Million | ▼ -776.5% |
| 2014 | -0.16x | $-5.67 Million | $36.58 Million | ▲ +84.8% |
| 2013 | -1.02x | $-19.48 Million | $19.13 Million | ▼ -122.3% |
| 2012 | -0.46x | $-8.08 Million | $17.64 Million | ▲ +87.3% |
| 2011 | -3.59x | $-25.89 Million | $7.20 Million | ▼ -6.5% |
| 2010 | -3.37x | $-23.93 Million | $7.09 Million | ▼ -761.0% |
| 2009 | -0.39x | $-6.14 Million | $15.66 Million | ▲ +71.9% |
| 2008 | -1.39x | $-17.34 Million | $12.45 Million | ▼ -2.1% |
| 2007 | -1.36x | $-16.07 Million | $11.78 Million | ▲ +33.3% |
| 2006 | -2.05x | $-14.48 Million | $7.08 Million | ▼ -461.7% |
| 2005 | -0.36x | $-4.07 Million | $11.17 Million | ▲ +91.6% |
| 2004 | -4.33x | $-10.16 Million | $2.35 Million | ▲ +8.6% |
| 2003 | -4.74x | $-7.44 Million | $1.57 Million | ▲ +3.0% |
| 2002 | -4.88x | $-9.67 Million | $1.98 Million | ▼ -113.3% |
| 2001 | -2.29x | $-6.11 Million | $2.67 Million | ▼ -89.8% |
| 2000 | -1.21x | $-2.45 Million | $2.04 Million | ▲ +34.7% |
| 1999 | -1.85x | $-2.40 Million | $1.30 Million | — |